| Valuation method | Value, £ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | n/a | n/a |
| Intrinsic value (DCF) | n/a | |
| Graham-Dodd Method | n/a | |
| Graham Formula | n/a |
Clean Power Hydrogen Plc (CPH2.L) is a UK-based green hydrogen technology and manufacturing company specializing in membrane-free electrolyser solutions. Founded in 2012 and headquartered in Doncaster, the company focuses on producing high-purity green hydrogen and medical-grade oxygen for industries such as power generation, manufacturing, transportation, and hydroculture. Clean Power Hydrogen's innovative technology differentiates it in the renewable utilities sector by offering a scalable and efficient alternative to traditional hydrogen production methods. As global demand for clean energy solutions grows, CPH2 is positioned to capitalize on the transition toward decarbonization, particularly in Europe, where hydrogen infrastructure is rapidly expanding. The company's focus on sustainability and technological advancement makes it a key player in the green hydrogen market.
Clean Power Hydrogen Plc presents a high-risk, high-reward investment opportunity in the emerging green hydrogen sector. The company's membrane-free electrolyser technology offers a unique value proposition, but its financials reflect early-stage challenges, including negative net income (-£4.1M in FY 2023) and negative operating cash flow (-£5.9M). With no revenue reported and significant cash burn, investors must weigh the long-term potential of hydrogen adoption against near-term financial instability. The company's low beta (0.202) suggests limited correlation with broader market movements, which may appeal to speculative investors seeking niche exposure. However, competition from larger, better-capitalized players and reliance on government subsidies for hydrogen projects add to the risk profile.
Clean Power Hydrogen Plc competes in the rapidly evolving green hydrogen market, where its membrane-free electrolyser technology provides a key differentiator. Unlike conventional alkaline or PEM electrolysers, CPH2's system avoids costly membranes, potentially reducing maintenance and improving longevity. However, the company faces intense competition from established players with greater scale and financial resources. Its UK focus may limit immediate growth compared to competitors with global supply chains. The lack of revenue indicates that commercial deployment is still in early stages, whereas rivals like ITM Power and Nel ASA already have operational projects. CPH2's small market cap (£22.2M) restricts its ability to invest in R&D and scaling at the same pace as larger competitors. Success will depend on securing strategic partnerships, government grants, and demonstrating cost advantages in real-world applications.